Milestone Pharmaceuticals Inc. (MIST) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
10/25
Growth 3
Margin 1
Expansion 3
Platform 1
Financial 2
latest quarter score
Earnings Reports
- 10
- 9
- 9